Classes
DEA Class; Rx
Common Brand Names; INFeD, Dexferrum
- Iron Products
Description
Parenteral iron supplement of ferric oxyhydroxide complexed with dextrans; rapidly repletes iron stores in deficiency from anemia or blood loss; sometimes associated with severe hypersensitivity.
Indications
Indicated for the treatment of iron-deficiency anemia in patients in whom oral iron administration is unsatisfactory or impossible.
Contraindications
History of hypersensitivity to product or excipients
Adverse Effects
- Abdominal pain
- Diarrhea
- Nausea
- Vomiting
- Arthralgia
- Arthritis
- Soreness
- Inflammation
- Pruritus
- Rash
- Urticaria
- Brown discoloration of skin
Warnings
—
Pregnancy and Lactation
There are no adequate and well-controlled studies in pregnant women; should be used during pregnancy only if potential benefit justifies potential risk to fetus
Exercise caution when product is administered to a nursing woman; traces of unmetabolized iron dextran are excreted in human milk
Maximum Dosage
Total dosage with iron dextran must be individualized according to the patients age, weight, and the degree of the iron-deficiency anemia. Excess accumulation may occur if iron therapy is continued after the correction of the deficiency. The following are generally accepted limits in the treatment of iron-deficient patients.
100 mg/day IV or IM. See individual dosage if using total dose IV infusion methods.
100 mg/day IV or IM. See individual dosage if using total dose IV infusion methods.
100 mg/day IV or IM. See individual dosage if using total dose IV infusion methods.
10 kg or more: 100 mg/day IV or IM. See individual dosage if using total dose IV infusion methods.
5 to 9.9 kg: 50 mg/day IV or IM.
4 months and older (weight 5 to 9.9 kg): 50 mg/day IV or IM.
4 months and older (weight less than 5 kg): 25 mg/day IV or IM.
1 to 3 months: Safety and efficacy have not been established.
Safety and efficacy have not been established.
How supplied
Iron dextran complex
injectable solution
- 50mg (Fe)/mL
